Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05503797
Title A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Fore Biotherapeutics
Age Groups: child | adult | senior
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | CAN

Additional content available in CKB BOOST